Sandip Patel

COVID-19 and vaccination: myths vs science

Vivek P. Chavda, V. Apostolopoulos, V. Uversky, 2022, Expert review of vaccines.

Immunogenicity in Mamu-A*01 rhesus macaques of a CCR5-tropic human immunodeficiency virus type 1 envelope from the primary isolate (Bx08) after synthetic DNA prime and recombinant adenovirus 5 boost.

H. Ertl, James M. Wilson, L. Vinner, 2003, The Journal of general virology.

A human immunodeficiency virus 1 (HIV-1) clade A vaccine in clinical trials: stimulation of HIV-specific T-cell responses by DNA and recombinant modified vaccinia virus Ankara (MVA) vaccines in humans.

S. Rowland-Jones, A. McMichael, H. McShane, 2004, The Journal of general virology.

Development of a DNA-MVA/HIVA vaccine for Kenya.

A. McMichael, T. Hanke, J. Sutton, 2002, Vaccine.

A DNA/MVA-based candidate human immunodeficiency virus vaccine for Kenya induces multi-specific T cell responses in rhesus macaques.

A. McMichael, T. Hanke, E. Wee, 2002, The Journal of general virology.